Skip to content
value.today
OraSure Technologies, Inc. logo

OraSure Technologies, Inc.

OSUR
$262 Mmarket cap on Oct 23, 2026-56.0% since Jan 2024
Compare
World rank
#15,291
Revenue
$115 M
For year ending December-2025
Net income
$-69 M
-59.8% margin
SEC filing
Employees
785
As on 2021
value.today research

OraSure Technologies, Inc. in brief

OraSure Technologies, Inc. is a listed company in the Medical Instruments industry, based in Bethlehem, Pennsylvania, USA. It was founded in 1987. Its market value was $262 M on 23 October 2026, which makes it the 15,291st largest listed company in the world and the 2,980th largest in the USA on this site. In the year to December 2025 it had sales of $115 M and a net loss of $69 M. It employs about 785 people and Manner Carrie Eglinton is its chief executive. Its largest product and service lines by sales in 2025 were Products and services (95%). By market, the largest shares of its 2025 sales came from USA (68%), Africa (21%) and Europe (6%). Its shares trade under the symbol OSUR (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About OraSure Technologies, Inc.

OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.

From Wikipedia: read the full article · text available under CC BY-SA 4.0

OraSure Technologies, Inc. timeline

5 events, 1987–2023
  1. 1987
  2. 🏁
    · approximate
    Founded
  3. 2000
  4. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  5. 2018
  6. •
    Legal Entity Identifier issued
    LEI 529900GNNJPNM4XHXQ77 registered.
  7. 2023
  8. 💰
    Record revenue of $405 million
    FY2023, the highest of the 8 years on record.
  9. 💰
    Record net income of $54 million
    FY2023, the highest profit of the 3 years on record.

Events of OraSure Technologies, Inc. from the company record, SEC EDGAR, the GLEIF LEI register and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$205 M$411 M$616 M$822 M2020202120222023202420252026

World rank over time

▼ down 4,186 places since 2020
2020-01-01: #11145#11,14520202021-01-01: #9153#9,15320212022-01-07: #12608#12,60820222022-12-25: #14885#14,88520222023-07-30: #15152#15,15220232024-01-05: #11525#11,52520242026-03-08: #8792#8,79220262026-08-01: #14607#14,60720262026-10-23: #15331#15,3312026

Rank in USA: #2,499 (Jan 2020) · #2,420 (Jan 2021) · #3,104 (Jan 2022) · #3,057 (Dec 2022) · #3,073 (Jul 2023) · #2,394 (Jan 2024) · #1,645 (Mar 2026) · #2,949 (Aug 2026) · #2,984 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
2.3×
Price / book
0.8×
Free cash flow yield
-20.3%
Net margin (TTM)
-41.7%
Operating margin
-62.6%
Return on equity
-14.2%
Liabilities / assets
15.5%
Revenue growth
-38.1%
R&D / revenue
37.0%
Revenue per employee
$147 K
Profit per employee
$-88 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue $182M, net income $20M$182MFY18Fiscal year ending Dec 2019: revenue $155M, net income $17M$155MFY19Fiscal year ending Dec 2020: revenue $172M, net income $-15M$172MFY20Fiscal year ending Dec 2021: revenue $234M, net income $-23M$234MFY21Fiscal year ending Dec 2022: revenue $387M, net income $-17M$387MFY22Fiscal year ending Dec 2023: revenue $405M, net income $54M$405MFY23Fiscal year ending Dec 2024: revenue $186M, net income $-20M$186MFY24Fiscal year ending Dec 2025: revenue $115M, net income $-69M$115MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$115M-38.1%$-72M$-69M-59.8%
Dec 2024$186M-54.2%$-28M$-20M-10.5%
Dec 2023$405M+4.6%$33M$54M13.2%
Dec 2022$387M+65.8%$-22M$-17M-4.4%
Dec 2021$234M+36.1%$-10M$-23M-9.8%
Dec 2020$172M+11.1%$-5M$-15M-8.7%
Dec 2019$155M-14.9%$19M$17M10.8%
Dec 2018$182M—$28M$20M11.2%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-49M$4M$-53M$-0.94—
Dec 2024$27M$4M$24M$-0.26—
Dec 2023$142M$6M$136M$0.72—
Dec 2022$-47M$7M$-54M$-0.24—
Dec 2021$-35M$22M$-57M$-0.32—
Dec 2020$6M$27M$-21M$0.22—
Dec 2019$10M$9M$0M$0.27—
Dec 2018$39M$6M$33M$0.33—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$116M
Net income, trailing 12 months
$-49M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $37M, net income $-11M$37MDec ’24Three months to Mar 2025: revenue $30M, net income $-16M$30MMar ’25Three months to Jun 2025: revenue $31M, net income $-20M$31MJun ’25Three months to Sep 2025: revenue $27M, net income $-14M$27MSep ’25Three months to Dec 2025 (from the annual report): revenue $27M, net income $-19M$27MDec ’25Three months to Mar 2026: revenue $28M, net income $-22M$28MMar ’26Three months to Jun 2026: revenue $31M, net income $6M$31MJun ’26Three months to Sep 2026: revenue $31M, net income $-13M$31MSep ’26

Latest quarter to Sep 2026: revenue $31M (+14.1% on a year earlier), net income $-13M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of OraSure Technologies, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$115 M
Operating income
$-72 M
Net income
$-69 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$403 M
Total liabilities
$62 M
Total equity
$341 M

As of December-2025

Top 100 institutional investors in OraSure Technologies, Inc.#

As of Sep 30, 2026
146 institutions held 56.9 M shares (about 82.4% of the shares outstanding) on Sep 30, 2026. The ten largest hold 48.0%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in OraSure Technologies, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1BlackRock, Inc.6,073,705-183,057 (-2.93%)8.80%$24 MNov 13, 2026
2Neuberger Berman Group LLC4,089,876-595,556 (-12.71%)5.92%$16 MNov 13, 2026
3Yorkville Advisors Global, LP3,929,970New5.69%$15 MNov 12, 2026
4Altai Capital Management, L.P.3,613,8360 (0.00%)5.23%$14 MNov 16, 2026
5Private Management Group Inc3,180,007-617,675 (-16.26%)4.61%$12 MNov 4, 2026
6Systematic Financial Management LP3,148,036+290,062 (+10.15%)4.56%$12 MNov 16, 2026
7Vanguard Capital Management LLC2,900,213-118,694 (-3.93%)4.20%$11 MNov 13, 2026
8Dimensional Fund Advisors LP2,255,527-85,374 (-3.65%)3.27%$9 MNov 4, 2026
9Acadian Asset Management LLC2,022,1190 (0.00%)2.93%$8 MNov 9, 2026
10Renaissance Technologies LLC1,954,203-60,700 (-3.01%)2.83%$8 MNov 12, 2026
11Gagnon Securities LLC1,826,604+234,457 (+14.73%)2.65%$7 MNov 5, 2026
12State Street Corp1,655,581-31,028 (-1.84%)2.40%$6 MNov 12, 2026
13First Eagle Investment Management, LLC1,637,964-487,536 (-22.94%)2.37%$6 MNov 10, 2026
14Geode Capital Management, LLC1,606,059-201,830 (-11.16%)2.33%$6 MNov 6, 2026
15Gagnon Advisors, LLC1,285,032+77,592 (+6.43%)1.86%$5 MNov 6, 2026
16Peapod Lane Capital LLC928,592-65,283 (-6.57%)1.34%$4 MOct 22, 2026
17Wells Fargo & Company/mn885,047-38,983 (-4.22%)1.28%$3 MNov 16, 2026
18D. E. Shaw & Co., Inc.703,682-123,505 (-14.93%)1.02%$3 MNov 16, 2026
19Jacobs Levy Equity Management, Inc688,715-156,220 (-18.49%)1.00%$3 MNov 16, 2026
20Jpmorgan Chase & Co621,687+32,510 (+5.52%)0.90%$2 MNov 12, 2026
21Vanguard Portfolio Management LLC612,575-11,089 (-1.78%)0.89%$2 MNov 13, 2026
22Goldman Sachs Group Inc611,624+49,974 (+8.90%)0.89%$2 MNov 16, 2026
23Bank Of America Corp /de/589,932+532,555 (+928.17%)0.85%$2 MNov 16, 2026
24Charles Schwab Investment Management Inc574,898-4,685 (-0.81%)0.83%$2 MNov 16, 2026
25Orion Porfolio Solutions, LLC571,397+234,998 (+69.86%)0.83%$2 MNov 12, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in OraSure Technologies, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Cannell Capital LLC568,071-859,348 (-60.20%)0.82%$2 MNov 16, 2026
27Northern Trust Corp551,920-35,488 (-6.04%)0.80%$2 MNov 16, 2026
28Tudor Investment Corp Et Al498,847+98,018 (+24.45%)0.72%$2 MNov 16, 2026
29Vanguard Fiduciary Trust Co430,160-27,907 (-6.09%)0.62%$2 MNov 13, 2026
30UBS Group AG412,751+152,765 (+58.76%)0.60%$2 MNov 10, 2026
31Morgan Stanley394,264+58,628 (+17.47%)0.57%$2 MNov 13, 2026
32KLP Kapitalforvaltning As363,3000 (0.00%)0.53%$1 MNov 10, 2026
33Man Group plc269,139+118,285 (+78.41%)0.39%$1 MNov 16, 2026
34AQR Capital Management LLC238,930-80,913 (-25.30%)0.35%$1 MNov 16, 2026
35Price T Rowe Associates Inc /MD/231,771+1,601 (+0.70%)0.34%$1 MNov 16, 2026
36Pavaki Capital Management LLC219,0330 (0.00%)0.32%$1 MOct 26, 2026
37Strs Ohio216,300+59,400 (+37.86%)0.31%$1 MOct 30, 2026
38SEI Investments Co203,876-634 (-0.31%)0.30%$1 MNov 10, 2026
39BlueCrest Capital Management Ltd200,000New0.29%$1 MNov 13, 2026
40Bank of New York Mellon Corp199,919-7,700 (-3.71%)0.29%$1 MNov 5, 2026
41American Century Companies Inc179,487-10,236 (-5.40%)0.26%$1 MNov 12, 2026
42Invesco Ltd.174,625+41,658 (+31.33%)0.25%$1 MNov 12, 2026
43Point72 Asset Management, L.P.172,502New0.25%$1 MNov 16, 2026
44Gsa Capital Partners LLP168,086New0.24%$1 MNov 16, 2026
45Ameriprise Financial Inc167,920-8,132 (-4.62%)0.24%$1 MNov 16, 2026
46HRT Financial LP150,491New0.22%$1 MNov 13, 2026
47Jump Financial, LLC138,900New0.20%$1 MNov 13, 2026
48Odyssean, LLC133,9370 (0.00%)0.19%$1 MNov 16, 2026
49Nuveen, LLC131,361+29 (+0.02%)0.19%$1 MNov 10, 2026
50Barclays PLC124,396+17,457 (+16.32%)0.18%$0 MNov 6, 2026
51Boothbay Fund Management, LLC124,028+89,254 (+256.67%)0.18%$0 MNov 16, 2026
52HSBC Holdings PLC115,405-4,025 (-3.37%)0.17%$0 MNov 16, 2026
53Alliancebernstein L.P.108,8160 (0.00%)0.16%$0 MNov 16, 2026
54Bridgeway Capital Management, LLC103,647-31,512 (-23.31%)0.15%$0 MNov 16, 2026
55Fuller & Thaler Asset Management, Inc.99,749+1,350 (+1.37%)0.14%$0 MNov 13, 2026
56Citadel Advisors LLC91,291-10,667 (-10.46%)0.13%$0 MNov 16, 2026
57Qube Research & Technologies Ltd89,529New0.13%$0 MNov 13, 2026
58Empowered Funds, LLC88,488New0.13%$0 MNov 13, 2026
59Murphy Pohlad Asset Management LLC85,667-20,600 (-19.39%)0.12%$0 MOct 22, 2026
60Rhumbline Advisers85,387-2,877 (-3.26%)0.12%$0 MNov 10, 2026
61Deutsche Bank AG\85,145-33,080 (-27.98%)0.12%$0 MNov 6, 2026
62Russell Investments Group, Ltd.79,651+7,897 (+11.01%)0.12%$0 MNov 6, 2026
63Two Sigma Investments, LP72,742+13,442 (+22.67%)0.11%$0 MNov 16, 2026
64FMR LLC70,062+59,737 (+578.57%)0.10%$0 MNov 10, 2026
65Occudo Quantitative Strategies LP68,248New0.10%$0 MNov 16, 2026
66Engineers Gate Manager LP47,958New0.07%$0 MNov 16, 2026
67NewEdge Advisors, LLC47,759-502 (-1.04%)0.07%$0 MNov 13, 2026
68Quadrature Capital Ltd44,484+16,569 (+59.36%)0.06%$0 MNov 13, 2026
69Arrowstreet Capital, Limited Partnership42,983-103,042 (-70.56%)0.06%$0 MNov 13, 2026
70Millennium Management LLC42,415-145,908 (-77.48%)0.06%$0 MNov 16, 2026
71Susquehanna International Group, LLP39,079-159,700 (-80.34%)0.06%$0 MNov 16, 2026
72MetLife Investment Management, LLC37,593-983 (-2.55%)0.05%$0 MNov 16, 2026
73Franklin Templeton Inc36,390New0.05%$0 MNov 12, 2026
74Metis Global Partners, LLC34,4300 (0.00%)0.05%$0 MNov 13, 2026
75State Board Of Administration Of Florida Retirement System34,3380 (0.00%)0.05%$0 MNov 13, 2026
76MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.31,791+1,597 (+5.29%)0.05%$0 MNov 16, 2026
77Centiva Capital, LP31,658New0.05%$0 MNov 13, 2026
78Manatuck Hill Partners, LLC30,0000 (0.00%)0.04%$0 MNov 16, 2026
79Graham Capital Management, L.P.26,034-18,267 (-41.23%)0.04%$0 MNov 16, 2026
80Vanguard Global Advisers, LLC25,884+309 (+1.21%)0.04%$0 MNov 13, 2026
81Bfsg, LLC24,970-2,650 (-9.59%)0.04%$0 MOct 30, 2026
82Significant Wealth Partners LLC20,401-31 (-0.15%)0.03%$0 MNov 12, 2026
83OneDigital Investment Advisors LLC20,290-184 (-0.90%)0.03%$0 MNov 10, 2026
84Manufacturers Life Insurance Company, The19,742-809 (-3.94%)0.03%$0 MNov 13, 2026
85New York State Common Retirement Fund19,3070 (0.00%)0.03%$0 MNov 17, 2026
86LPL Financial LLC17,278-1,350 (-7.25%)0.03%$0 MNov 6, 2026
87Vanguard Personalized Indexing Management, LLC16,7750 (0.00%)0.02%$0 MNov 16, 2026
88Public Employees Retirement Association Of Colorado16,4760 (0.00%)0.02%$0 MNov 12, 2026
89Quantinno Capital Management LP16,307-4,306 (-20.89%)0.02%$0 MNov 13, 2026
90Coldstream Capital Management Inc15,475-2,504 (-13.93%)0.02%$0 MNov 9, 2026
91Quadrant Private Wealth Management, LLC15,260-5,000 (-24.68%)0.02%$0 MNov 4, 2026
92Voya Investment Management LLC15,123-1,075 (-6.64%)0.02%$0 MNov 10, 2026
93PNC Financial Services Group, Inc.15,089+1,214 (+8.75%)0.02%$0 MNov 6, 2026
94Shikiar Asset Management Inc15,0000 (0.00%)0.02%$0 MOct 20, 2026
95Moors & Cabot, Inc.14,7550 (0.00%)0.02%$0 MNov 6, 2026
96Police & Firemen's Retirement System of New Jersey13,744-9,938 (-41.96%)0.02%$0 MNov 9, 2026
97BNP Paribas Financial Markets13,743+5,519 (+67.11%)0.02%$0 MNov 12, 2026
98Marshall Wace, LLP13,200-11,000 (-45.45%)0.02%$0 MNov 13, 2026
99State Of Wisconsin Investment Board12,978-34,719 (-72.79%)0.02%$0 MNov 16, 2026
100Schonfeld Strategic Advisors LLC11,935-15,060 (-55.79%)0.02%$0 MNov 16, 2026

All 146 institutional investors, with who bought and sold →

Mutual funds holding OraSure Technologies, Inc.#

133 funds hold shares worth $70 M (about 23.6% of the company). Since their previous reports 39 added shares and 46 sold, buying $3 M net.
Mutual funds holding OraSure Technologies, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.2.15 M$10 M3.1%<0.01%no changeJun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors1.75 M$8 M2.5%<0.01%−0.9%Jun 30, 2026
🇺🇸 Neuberger Intrinsic Value FundNeuberger Berman Investment Advisers LLC1.10 M$5 M1.6%0.32%−0.1%May 31, 2026
🇺🇸 First Eagle Small Cap Opportunity FundFirst Eagle Investment Management, LLC1.17 M$5 M1.7%0.16%newJul 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.804,240$4 M1.2%<0.01%−0.4%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC716,191$3 M1.0%<0.01%+4.9%Jul 31, 2026
🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors601,153$3 M0.87%0.02%+2.3%Jun 30, 2026
🇺🇸 U.S. Small Cap Value PortfolioDimensional Fund Advisors LP589,210$2 M0.85%0.01%−15%Jul 31, 2026
🇺🇸 BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC446,639$2 M0.65%0.04%−1.3%May 29, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC397,761$2 M0.58%<0.01%−0.3%May 31, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.358,419$2 M0.52%<0.01%+2.4%May 31, 2026
🇺🇸 Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc.339,139$1 M0.49%<0.01%−4.7%May 31, 2026
🇺🇸 JPMorgan Small Cap Value FundJ.P. Morgan Investment Management Inc.297,538$1 M0.43%0.10%+83%Jun 30, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP306,565$1 M0.44%<0.01%+6.7%Jul 31, 2026
🇺🇸 Column Small Cap Select FundTrust for Professional Managers241,719$1 M0.35%0.05%+0.3%May 31, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP243,672$1 M0.35%0.01%+6.2%Jul 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors220,490$1 M0.32%0.06%+26%Jun 30, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP228,516$1 M0.33%<0.01%−7.7%Jul 31, 2026
🇺🇸 Vanguard Health Care Index FundThe Vanguard Group, Inc.195,698$1 M0.28%<0.01%+3.6%May 31, 2026
🇺🇸 Multi-Manager Small Cap Equity Strategies FundColumbia Funds Series Trust I176,052$1 M0.25%0.06%−19%May 31, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP185,265$1 M0.27%<0.01%+24%Jul 31, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.154,509$1 M0.22%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC140,145$1 M0.20%<0.01%no changeMay 31, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust133,206$1 M0.19%0.02%−6.8%May 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC124,041$1 M0.18%<0.01%no changeJun 30, 2026
🇺🇸 iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors123,087$1 M0.18%<0.01%+2.5%Jun 30, 2026
🇺🇸 NVIT Multi-Manager Small Company FundNATIONWIDE FUND ADVISORS116,069$1 M0.17%0.11%−16%Jun 30, 2026
🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P.113,825$0 M0.16%0.05%+1.3%May 31, 2026
🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC105,000$0 M0.15%0.32%no changeJun 30, 2026
🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP115,021$0 M0.17%<0.01%no changeJul 31, 2026
🇺🇸 NVIT Small Cap Value FundNATIONWIDE FUND ADVISORS104,238$0 M0.15%0.21%−12%Jun 30, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC107,296$0 M0.16%<0.01%+2.7%May 31, 2026
🇺🇸 U.S. Core Equity 1 PortfolioDimensional Fund Advisors LP103,715$0 M0.15%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC91,514$0 M0.13%0.02%+5.5%Jun 30, 2026
🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC90,352$0 M0.13%0.05%−4.9%May 31, 2026
🇺🇸 Transamerica Small/Mid Cap ValueTransamerica Asset Management, Inc.93,700$0 M0.14%0.06%+8.6%Jul 31, 2026
🇺🇸 Small Cap Equity FundGuideStone Capital Management, LLC78,730$0 M0.11%0.03%−44%Jun 30, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC75,678$0 M0.11%<0.01%−7.6%Jun 30, 2026
🇺🇸 JPMorgan Small Cap Value PortfolioBrighthouse Investment Advisers, LLC74,915$0 M0.11%0.10%+72%Jun 30, 2026
🇺🇸 Transamerica Small/Mid Cap Value VPTransamerica Asset Management, Inc.73,800$0 M0.11%0.06%−0.3%Jun 30, 2026
🇺🇸 JPMorgan Diversified Return U.S. Small Cap Equity ETFJ.P. Morgan Investment Management Inc.81,069$0 M0.12%0.06%+3.7%Jul 31, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC70,686$0 M0.10%0.02%+0.4%Jun 30, 2026
🇺🇸 Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC74,228$0 M0.11%0.01%−29%Jul 31, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC71,140$0 M0.10%<0.01%−28%Jul 31, 2026
🇺🇸 Dimensional US Small Cap Value ETFDimensional Fund Advisors LP61,708$0 M0.09%<0.01%−11%Jul 31, 2026
🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc.53,758$0 M0.08%0.02%−3.1%May 31, 2026
🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC55,033$0 M0.08%<0.01%no changeJul 31, 2026
🇺🇸 Schwab U.S. Broad Market ETFCharles Schwab Investment Management, Inc.51,155$0 M0.07%<0.01%+0.9%May 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation49,206$0 M0.07%<0.01%−7.2%Jun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.45,433$0 M0.07%<0.01%+71%Jun 30, 2026
🇺🇸 Avantis U.S. Equity ETFAmerican Century ETF Trust44,087$0 M0.06%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC43,371$0 M0.06%<0.01%no changeMay 31, 2026
🇺🇸 Column Small Cap FundTrust for Professional Managers41,233$0 M0.06%0.03%no changeMay 31, 2026
🇺🇸 Transamerica Small Cap ValueTransamerica Asset Management, Inc.43,500$0 M0.06%0.16%+26%Jul 31, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.36,693$0 M0.05%<0.01%−20%Jun 30, 2026
🇺🇸 U.S. Vector Equity PortfolioDimensional Fund Advisors LP39,492$0 M0.06%<0.01%+199%Jul 31, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC35,020$0 M0.05%<0.01%−32%Jun 30, 2026
🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC37,455$0 M0.05%<0.01%+14%Jul 31, 2026
🇺🇸 Bridge Builder Small/Mid Cap Value FundOLIVE STREET INVESTMENT ADVISERS LLC33,395$0 M0.05%<0.01%no changeJun 30, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.32,916$0 M0.05%<0.01%+12%Jun 30, 2026
🇺🇸 T. Rowe Price Extended Equity Market Index FundT. Rowe Price Associates, Inc.31,882$0 M0.05%0.01%no changeJun 30, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.35,000$0 M0.05%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.30,211$0 M0.04%<0.01%no changeJun 30, 2026
🇺🇸 Small Cap Value FundThe Variable Annuity Life Insurance Company31,160$0 M0.05%0.05%−11%May 31, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company30,575$0 M0.04%<0.01%no changeMay 31, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC31,322$0 M0.05%<0.01%+3.8%Jul 31, 2026
🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC25,821$0 M0.04%<0.01%−2.1%Jul 31, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.23,000$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC21,650$0 M0.03%<0.01%−5.3%Jun 30, 2026
🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors20,750$0 M0.03%<0.01%−0.8%Jun 30, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC20,519$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors16,567$0 M0.02%<0.01%−24%Jun 30, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION16,939$0 M0.02%<0.01%no changeMay 31, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC16,106$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS15,628$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC15,247$0 M0.02%0.01%+8.1%Jun 30, 2026
🇺🇸 Omni Small-Cap Value FundBridgeway Capital Management, LLC15,000$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC14,652$0 M0.02%0.03%+17%Jun 30, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC14,307$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP13,900$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 Small Cap Core FundNorthern Trust Investments, Inc.11,732$0 M0.02%0.01%−4.6%Jun 30, 2026
🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC10,936$0 M0.02%0.01%+16%Jun 30, 2026
🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP11,179$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC11,090$0 M0.02%0.01%+2.4%Jul 31, 2026
🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP11,009$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC9,840$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Vericimetry U.S. Small Cap Value FundVericimetry Funds9,693$0 M0.01%0.02%+87%Jun 30, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.9,491$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC10,337$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC8,690$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.8,556$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Avantis U.S. Small Cap Equity FundAmerican Century ETF Trust8,199$0 M0.01%0.03%no changeMay 31, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management7,452$0 M0.01%0.01%no changeJun 30, 2026
🇺🇸 Dimensional US Core Equity Market ETFDimensional Fund Advisors LP8,145$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC7,789$0 M0.01%<0.01%−26%Jul 31, 2026
🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc.6,831$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc.7,490$0 M0.01%<0.01%+0.4%Jul 31, 2026
🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC6,570$0 M<0.01%<0.01%+40%Jun 30, 2026
🇺🇸 Dimensional US Vector Equity ETFDimensional Fund Advisors LP7,100$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP7,000$0 M0.01%<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at OraSure Technologies, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$456 K
8 purchases, 4 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$456 K
open market only
Insiders on file
39
since
$761 K-$194 K$0Dec 2023: bought $0 (0 trades), sold $194 K (1 trades)Dec 23Feb 2025: bought $761 K (6 trades), sold $0 (0 trades)FebNov 2025: bought $5 K (1 trades), sold $0 (0 trades)NovMar 2026: bought $227 K (4 trades), sold $0 (0 trades)MarMay 2026: bought $225 K (3 trades), sold $0 (0 trades)May
Bought (open market)Sold (open market)Hover a month for the totals
OraSure Technologies, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Steven Kyle BoydDirectorGrant or award+4,797$3.880$19 K168,031Form 4
filed John P. KennyDirectorShares withheld for tax-5,116$3.430$18 K204,598Form 4
filed Steven Kyle BoydDirectorGrant or award+3,666$4.430$16 K163,234Form 4
filed Robert W. McMahonDirectorGrant or award+46,106——123,137Form 4
filed Nancy J. GaglianoDirectorGrant or award+46,106——185,055Form 4
filed John D. BertrandDirectorGrant or award+46,106——79,767Form 4
filed Steven Kyle BoydDirectorGrant or award+46,106——159,568Form 4
filed Lelio MarmoraDirectorGrant or award+46,106——148,460Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: OraSure Technologies, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
2.6 M
3.7% of shares · 3.64 days to cover
Buybacks, Q3 2026
$0M
Q3 2026
Shares sold short, last 24 reportsAll stocks →
OraSure Technologies, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q3 2026Q3 2026$0M
Q2 2026Q2 2026$2M
Q1 2026Q1 2026$5M
Q4 2025Q4 2025$5M
Q3 2025Q3 2025$5M
Q2 2025Q2 2025$5M
Q1 2025Q1 2025$0M
Q4 2024Q4 2024$0M
Q3 2024Q3 2024$0M
Q1 2024Q1 2024$1.5M
Q3 2023Q3 2023$0.2M
Q2 2023Q2 2023$0.5M
Q1 2023Q1 2023$1.2M
Q4 2022Q4 2022$0.2M
Q3 2022Q3 2022$0.1M
Q2 2022Q2 2022$0.9M

Trading halts

  • 2025-02-26 14:31 UTC, code LUDP, resumed 14:36 UTC

Fails to deliver

  • : 1,106 shares at $3.80
  • : 14,635 shares at $3.39
  • : 4,133 shares at $3.58
  • : 88 shares at $3.53
  • : 745 shares at $3.60

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

OraSure Technologies, Inc. scorecard#

Passes 6 of the 23 checks that could be worked out: strongest in financial health (2 of 3), weakest in growth (0 of 6). Fiscal year 2025; market cap of Oct 23, 2026.

  • Valuation2 of 6
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✓Price to book below its peers' median0.8×Price to book 0.8× against Medical Instruments's median of 3.9×.
    • ✓Price to sales below its peers' median2.3×Price to sales 2.3× against Medical Instruments's median of 3.0×.
    • ✗Free cash flow yield above 5%-20.3%Free cash flow is -20.3% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • ✗The price assumes slower growth than the last three years'-5.9%The price assumes -5.9% a year for ten years; revenue grew -33.3% a year over the last three.
  • Growth0 of 6
    • ✗Revenue grew in the newest year-38.1%Revenue down 38.1% in fiscal 2025.
    • ✗Revenue up more than 5% a year over three years-33.3%-33.3% a year over the three years to fiscal 2025.
    • ✗Faster growth over three years than its peers' median-33.3%-33.3% a year against Medical Instruments's median of 5.0% (37 companies).
    • ✗Earnings per share grew in the newest year-0.94 vs -0.26Diluted EPS -0.94 in fiscal 2025 against -0.26 the year before (report's currency).
    • ✗Net income higher than five years earlier-$69 M-$69 M in fiscal 2025 against -$15 M in 2020.
    • ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2025.
  • Profitability0 of 5
    • ✗Profitable in the newest year-$69 MNet income -$69 M in fiscal 2025.
    • ✗Profitable in each of the last five years1 of 5Profitable in 1 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median-62.6%-62.6% against Medical Instruments's median of 7.2% (46 companies).
    • ✗Return on equity above 15%-18.3%-18.3% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✗Operating margin wider than three years earlier-62.6%-62.6% in fiscal 2025 against -5.7% in 2022.
  • Financial health2 of 3
    • ✓Short-term assets cover short-term liabilities6.6×Current ratio 6.58 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years2 of 3Positive in 2 of the three years to fiscal 2025.
    • ✓Altman Z-score outside the distress zone2.28Z-score 2.28 (grey zone) for fiscal 2025.
  • Shareholder returns2 of 3
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✓Share count up no more than 2% in a year-1.3%Diluted shares down 1.3% in fiscal 2025.
    • ✓Dividends and buybacks above 3% of the market value5.7%Dividends and buybacks were 5.7% of the market value.
    • ✗Free cash flow covers dividends and buybacks-$53 MFree cash flow -$53 M against $15 M paid out in fiscal 2025.

Worked out from the statements as filed (sec), the medians of Medical Instruments, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from OraSure Technologies, Inc.'s statements, beside the median of Medical Instruments.

OraSure Technologies, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-62.6%7.2%
Net margin-59.8%3.8%
Return on equity-18.3%3.5%
Revenue growth, 3 years a year-33.3%5.0%
Revenue growth-38.1%8.9%
Free cash flow margin-46.3%6.3%

2of 8on the Piotroski tests of financial strength

  • Revenue fell 38.1% against the year before.
  • Net loss of $69 million.
  • Free cash flow was negative: -$53 million.

OraSure Technologies, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

OraSure Technologies, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue115186405387234172155182167128
Cost of revenue67106234239r1167060686840
Gross profit4879172148r118102951149988
Research and development4326343634312016139.8
Selling and marketing26313649453432312930
General and administrative48465868504335382928
Operating expenses12010813917112810776855968
Operating income−72−2833−22r−10−5.219284020
Interest and finance income8.1115.91.6——————
Share of profit of associates−2.3−1.700——————
Other non-operating income (expense)0.2−0.418r3.5r0.91.72.73.30.80.1
Income before tax−65−1656−16r−9.3−3.521324120
Income tax1.81.82.61.514114.711100.6
Net income including minority interests—−2054−17r−23−1517203120
Net income attributable to shareholders−69−2054−17r−23−1517203120
Earnings per share, basic-0.94-0.260.73-0.24r-0.320.22r0.270.330.520.35
Earnings per share, diluted-0.94-0.260.72-0.24r-0.320.22r0.270.330.510.35
Shares, weighted average (basic)73747373726862615956
Shares, weighted average (diluted)73747473726862636157
Balance sheet
Cash and cash equivalents19926829084117161768871108
Short-term investments——027364981688311
Receivables22244071453937354320
Inventory31344896r533223231912
Other current assets2.4r3.52.24240r4.95.73.12.52.1
Current assets262333386325r299r289225219222156
Property, plant and equipment3945455973r5230242120
Right-of-use (leased) assets121312109.14.55.0———
Goodwill43403635404036192019
Other intangible assets19171.2121418155.18.210
Long-term investments———01748334521—
Non-current assets14114696119162r16612596——
Total assets403480483444r461454349316296208
Accounts payable6.58.21338r28179.611104.6
Current liabilities40334069r684633283217
Lease liabilities (non-current)1112119.17.23.64.2———
Non-current liabilities23361311129.49.44.2——
Total liabilities62695280r80564232——
Retained earnings−172−103−84−138r−120−97−83−99−120−150
Shareholders' equity341410431364r381399307283258186
Total liabilities and equity403480483444r461454349316296208
Shares outstanding70757473727262616156
Cash-flow statement
Depreciation and amortization10112115129.47.36.56.1r5.7r
Share-based compensation101211127.87.14.1157.06.1
Cash from operating activities−4927142−47−355.89.8392825r
Capital expenditure−4.2−3.8−5.8−6.8−22r−27−9.3−6.3−4.3−4.4
Acquisitions, net of cash acquired−3.6−5.000—−3.0−24———
Cash from investing activities−6.8−396621−5.5−14−20−17−96−8.1
Debt repaid——————−0.7———
Shares issued—————95————
Shares bought back−150r0r−2.3−2.1−2.1−3.7−3.6−1.2−3.4
Cash from financing activities−17−4.2−3.0−3.8−2.892−4.7−1.930−1.2
Exchange-rate effect on cash————————0.80.3
Change in cash−68−23206−33−4485−1316−3716r
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What OraSure Technologies, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Products and services$109 M95%
  • Other$6 M5.2%

Countries and regions

  • 🇺🇸 USA$78 M68%
  • Africa$24 M21%
  • Europe$7 M6.4%
  • Other regions$5 M4.7%

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Executive pay at OraSure Technologies, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$4.3 M
Ms. Eglinton Manner
Other top executives, average
$1.6 M
the CEO earned 2.7× this
$100 invested is now
$23
peer group: $81
OraSure Technologies, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Ms. Eglinton Manner$4.3 M$671 K$1.6 M$23 (peers $81)
2024Ms. Eglinton Manner$5.6 M−$5.7 M$1.5 M$45 (peers $85)
2023Ms. Eglinton Manner$6.7 M$13.8 M$1.6 M$102 (peers $106)
2022Manner Carrie Eglinton$6.7 M$6.6 M$1.5 M$60 (peers $99)
2021Dr. Tang$3.0 M$2.7 M$1.1 M$108 (peers $125)

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at OraSure Technologies, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Acquisition or sale completed 1 · Directors and officers 8 · Material agreement 2 · Bylaws or fiscal year changed 2 · Shareholder vote 3 · Results announced 10

OraSure Technologies, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Results announced8-K
Directors and officersBylaws or fiscal year changedShareholder vote8-K
Results announced8-K
Directors and officersMaterial agreement8-K
Directors and officers8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Directors and officersShareholder vote8-K
Directors and officers8-K
Results announced8-K
Results announced8-K
Acquisition or sale completedMaterial agreement8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Directors and officersBylaws or fiscal year changedShareholder vote8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 9, 2026

Acquisitions and funding#

2 acquisitions, $32 M paid where reported

Businesses it acquired

Acquisitions by OraSure Technologies, Inc.
AcquiredAcquisition dateCompletionPriceStakeSource
BioMedomics, Inc2025—$4 M—Annual report
Sherlock Biosciences2024—$28 M—Annual report

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

Lobbying by OraSure Technologies, Inc.#

$40 K spent on lobbying the US Congress and federal agencies in 2025, most often on budget/appropriations and health issues.

Lobbying, 2025
$40 K
#1,388 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
1
in 2025
2026 so far
$30 K
  • Budget/Appropriations4 reports
  • Health Issues4 reports

Lobbying firms hired in 2025

Health and Medicine Counsel $40 K

OraSure Technologies, Inc.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2026 (so far)$30 K—3
2025$40 K—4
2024$40 K—4
2023$40 K—4
2022$40 K—4
2021$40 K—4
2020$40 K—4
2019$40 K—4
2018$40 K—4

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “ORASURE TECHNOLOGIES, INC.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

H-1B hiring at OraSure Technologies, Inc.#

3 labor condition applications certified in fiscal 2026 for 3 positions, at a median wage of $99 K a year.

Certified, FY2026
3
#1,355 among companies on value.today
Worker positions
3
Median wage offered
$99 K
a year, full-time
Applications filed
3
OraSure Technologies, Inc.: most frequent H-1B job titles in fiscal 2026
Job titlePositionsMedian wage offered
Manufacturing Engineer IIManufacturing Engineers2$99 K
Senior ScientistBiological Scientists, All Other1$91 K

Where: Bethlehem, PA 2 · Morrisville, NC 1

OraSure Technologies, Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202633$99 K3
FY202433$85 K3
FY202122$85 K2

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as ORASURE TECHNOLOGIES, INC.

Product recalls by OraSure Technologies, Inc.#

7 recalls since 2015, 26,582 units in the notices that give a number. Medical devices (FDA): 7.

OraSure Technologies, Inc.: product recalls
DateWhat and whyUnitsNotice
Methamphetamine Intercept Microplate kit EIA - IVD qualitative determination of methamphetamine in oral fluid, PN 11041C.Incorrect lot of Substrate Reagent (TMB) may be included in the kit. The original kit box labeling and the specification sheet listed the Substrate Reagent (TMB) lot 6676239, but contained Substrate Reagent (TMB) lot 6679623, should not affect performance.Medical devicesClass III16Z-1183-2021
Pointts sistema de ellmlnact!;o de verrugas OTC - Brazil Catalog Number: 1001-0280 - Product Usage: indicated for over-the-counter a cryosurgical system for the treatment of skin tags. (and 2 more products)Unit boxes not properly sealedMedical devicesClass III23,220Z-3003-2020
Orasure Technologies Interept Benzodiazopene Miro-Plate EIA-Benzo EIA 2 plate Matrix Oral Fluid Coated Micro-Plate. IVD Immunoassay for Benzodiazepines, Product Number: 1110IT (and 1 more products)Incorrect lot number for Standard Oral Fluid Negative Calibrator on specification sheet included in kit and/or additionally same error on unit boxMedical devicesClass III13Z-2877-2020
Cocaine Metabolite MICRO-PLATE EIA, Catalog Number: 1122SC, UDI: (0100608337000429(17)180228(10)000The controls and calibrators contained within the cocaine test kit may cause false positive results with the negative control.Medical devicesClass III10Z-1419-2018
Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay, barbiturate) Product is intended for use by clinical laboratories in the qualitative determination of barbiturates in oral fluids.Shipping error. Cocaine metabolite Microplate distributed instead of Barbiturate Microplate due to incorrect selection of Microplate during manufacturing.Medical devicesClass III4Z-0722-2017
OraQuick Ebola Rapid Antigen Test, Product Code 3001-2807; Intended for the qualitative detection of antigens for Ebola viruses.Failed stability testing at 8 months. This lot produced intermittent false negative results for the positive kit control with devices stored at 30C conditions.Medical devicesClass I3,075Z-2403-2016
OraQuick HCV Visual Reference Panel Intended to assist new operation in becoming proficient at reading specimens with antibody levels near the limit of detection of the device.OraSure Technologies, Inc. discovered the package insert included with the OraQuick HCV Rapid Antibody test Visual Reference Panel may be incorrect due to a complaint received from one of their customers. The customer reported they received the Ora Quick Ebola Visual Reference Panel instead of an OraQuick HCV Visual Reference Panel.Medical devicesClass III244Z-1509-2016

Source: NHTSA, CPSC and FDA recall notices. Recalls filed under a subsidiary with a different name may be missing. The number of recalls says nothing about their seriousness

How OraSure Technologies, Inc. compares in Medical Instruments

  • Market cap$262 M · higher than 29% of 116
  • Revenue$115 M · higher than 21% of 120
  • Net margin-41.7% · higher than 7% of 114
  • Revenue growth-38.1% · higher than 2% of 49
  • Price / sales2.3× · lower than 65% of 85
  • Price / book0.8× · lower than 95% of 84
  • FCF yield-20.3% · higher than 8% of 39

Peer comparison · Medical Instruments

CompanyMarket capP/ENet marginRev. growth
OraSure Technologies, Inc.🇺🇸$262 M—-41.7%-38.1%
Intuitive Surgical, Inc.🇺🇸$155.6 B52.6×25.5%+20.5%
EssilorLuxottica S.A.🇫🇷$88.0 B32.1×8.1%+4.5%
HOYA Corporation🇯🇵$56.2 B32.8×25.4%—
Becton, Dickinson and Company🇺🇸$54.0 B57.4×4.2%+8.2%
Alcon Inc.🇨🇭$37.1 B37.9×9.4%+4.9%
ResMed Inc.🇺🇸$35.3 B22.1×27.8%+9.8%
West Pharmaceutical Services, Inc.🇺🇸$27.1 B42.4×18.8%+6.3%
Terumo Corporation🇯🇵$24.9 B27.0×12.0%—

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 23, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As on 2021
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, Wikipedia, Wikidata, GLEIF register; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at OraSure Technologies, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show OraSure Technologies, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about OraSure Technologies, Inc.? Suggest a correction